The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Spring 2022 RFA: Cellular Phenotyping in Human iPSCS from the PPMI Cohort, 2022Metabolic Phenotyping in PD Dopaminergic Neurons and Neuronal-glial Co-cultures Using High-throughput Single-cell Metabolomics and Lipidomics
Study Rationale: Recent studies have discovered metabolism to be altered in Parkinson’s disease with cells changing their bioenergetic pathways and accumulating metabolite markers. Every cell in our...
-
Target Advancement Program, 2022Targeting GPR43 in T-cells as a Potential Treatment for Parkinson’s Disease
Study Rationale: Parkinson's disease involves the generation of pathogenic proteins in the neurons, which trigger an immune response driven by inflammatory lymphocytes that infiltrate the brain and...
-
Expanding Biological Understanding of Parkinson's Disease, 2022Evaluating the Role of Miro1 in Mitochondrial Quality Control in Parkinson’s Disease
Study Rationale: Growing evidence suggests that dysfunction is linked to Parkinson’s disease (PD). These structures supply cells with energy, but must be eliminated when they become damaged — a...
-
Fall 2021 RFP: Accelerating Early Proof-of-Concept Testing of Promising PD Therapies, 2022Therapeutic Efficacy of IC 100 in Small Models
Study Rationale: Parkinson’s disease (PD) is characterized by the loss of neurons in the brain. Despite available treatments, no approved therapy can slow disease progression. Data in humans and small...
-
Fall 2021 RFP: Outcome Measures, 2022Pet Imaging to Determine Regional and Temporal Trajectories of Reactive Astrocytosis in Parkinson’s Disease
Study Rationale: Neuroinflammation is a known process accompanying Parkinson’s disease (PD) neuropathology. During this process, specific brain cell populations become chronically activated, including...
-
Fall 2021 RFP: Outcome Measures, 2022LRRK2 Kinase Activity and Global Proteomic Biomarkers in the Gut of Patients with Parkinson’s and/or Inflammatory Bowl Disease
Study Rationale: Accumulative evidence suggests a strong connection between the brain and the gut, with chronic intestinal inflammation being linked to an increased risk of Parkinson’s disease (PD)...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.